ER+, HER2- Advanced Breast Cancer: Clinical Implications of the EMERALD Trial

Following their discussion of the EMERALD trial and elacestrant with Virginia Kaklamani, MD, DSc, the Oncology Brothers share clinical implications of the EMERALD trial to practice and look toward the future of ER+, HER2- advanced breast cancer management.

EP: 1.Overview of the EMERALD Trial of Elacestrant in ER+, HER2- Advanced Breast Cancer

EP: 2.EMERALD Trial of Elacestrant in ER+, HER2- Advanced Breast Cancer: Efficacy and Safety Data

Now Viewing

EP: 3.ER+, HER2- Advanced Breast Cancer: Clinical Implications of the EMERALD Trial

Related Videos